| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Wynne Sarah | Chief Financial Officer | 1350 EUCLID AVENUE, SUITE 1600, CLEVELAND | /s/ Rachel Quinlan as attorney in fact for Sarah Wynne | 06 Nov 2025 | 0001758252 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | TDG | Stock Option | Award | $0 | +8,700 | $0.000000 | 8,700 | 04 Nov 2025 | Common Stock | 8,700 | $1291.97 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | These options are exercisable at 50% per year in 2029 and 50% in 2030 subject to the achievement of annual operating performance targets in each year. |